Nachi Palaniappan

691 total citations
16 papers, 314 citations indexed

About

Nachi Palaniappan is a scholar working on Pulmonary and Respiratory Medicine, Otorhinolaryngology and Surgery. According to data from OpenAlex, Nachi Palaniappan has authored 16 papers receiving a total of 314 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pulmonary and Respiratory Medicine, 6 papers in Otorhinolaryngology and 4 papers in Surgery. Recurrent topics in Nachi Palaniappan's work include Head and Neck Cancer Studies (6 papers), Advanced Radiotherapy Techniques (3 papers) and Prostate Cancer Treatment and Research (3 papers). Nachi Palaniappan is often cited by papers focused on Head and Neck Cancer Studies (6 papers), Advanced Radiotherapy Techniques (3 papers) and Prostate Cancer Treatment and Research (3 papers). Nachi Palaniappan collaborates with scholars based in United Kingdom, United States and Switzerland. Nachi Palaniappan's co-authors include Mererid Evans, Ned Powell, Katherine A. Hutcheson, Chris Hurt, Max Robinson, Matthew Beasley, Sarah Townsend, Joanne Patterson, Emma Parsons and Terence M. Jones and has published in prestigious journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics and Radiotherapy and Oncology.

In The Last Decade

Nachi Palaniappan

15 papers receiving 313 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Nachi Palaniappan United Kingdom 8 218 171 87 73 32 16 314
Muhammad Shahid Iqbal United Kingdom 11 137 0.6× 120 0.7× 117 1.3× 116 1.6× 33 1.0× 45 289
Sebastião Francisco Miranda Corrêa Brazil 5 139 0.6× 94 0.5× 103 1.2× 45 0.6× 46 1.4× 5 295
F. Rosen United States 6 314 1.4× 219 1.3× 118 1.4× 152 2.1× 30 0.9× 10 399
Youwang Zhang China 7 193 0.9× 135 0.8× 99 1.1× 156 2.1× 13 0.4× 16 328
Abdullah Alamro Saudi Arabia 9 260 1.2× 175 1.0× 62 0.7× 150 2.1× 17 0.5× 18 372
Floyd Christopher Holsinger United States 7 226 1.0× 183 1.1× 111 1.3× 132 1.8× 11 0.3× 14 315
Luciana Lastrucci Italy 9 250 1.1× 131 0.8× 179 2.1× 111 1.5× 50 1.6× 12 344
Edvard Abel Sweden 8 128 0.6× 75 0.4× 115 1.3× 105 1.4× 21 0.7× 13 236
Michel Rives France 11 91 0.4× 108 0.6× 68 0.8× 107 1.5× 48 1.5× 17 244
Thierry Schmitt France 7 76 0.3× 100 0.6× 139 1.6× 68 0.9× 25 0.8× 11 283

Countries citing papers authored by Nachi Palaniappan

Since Specialization
Citations

This map shows the geographic impact of Nachi Palaniappan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nachi Palaniappan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nachi Palaniappan more than expected).

Fields of papers citing papers by Nachi Palaniappan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nachi Palaniappan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nachi Palaniappan. The network helps show where Nachi Palaniappan may publish in the future.

Co-authorship network of co-authors of Nachi Palaniappan

This figure shows the co-authorship network connecting the top 25 collaborators of Nachi Palaniappan. A scholar is included among the top collaborators of Nachi Palaniappan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nachi Palaniappan. Nachi Palaniappan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Price, James, MJ Tyler, James C. Lester, et al.. (2025). Primary results for the phase III trial of Toxicity Reduction using Proton Beam Therapy for Oropharyngeal Cancer (TORPEdO; CRUK/18/010). International Journal of Radiation Oncology*Biology*Physics. 123(4). 1195–1196.
2.
Palaniappan, Nachi, et al.. (2024). High-grade neuroendocrine head and neck cancer: Case series and review of the literature. Current Problems in Cancer. 51. 101105–101105. 1 indexed citations
3.
Patel, Priyanka, Gerhardt Attard, Aidan Cole, et al.. (2024). 3381: Primary endpoint analysis of TRAP, first prospective Phase II trial of SBRT to oligoprogressive disease prostate cancer (NCT03644303). Radiotherapy and Oncology. 194. S2643–S2645. 2 indexed citations
4.
Iqbal, Gulnaz, Tom Roques, Mark D. Evans, et al.. (2021). Improvement in Dysphagia Outcomes Following Clinical Target Volume Reduction in the De-ESCALaTE Study. Clinical Oncology. 33(12). 795–803. 4 indexed citations
5.
Palaniappan, Nachi, et al.. (2021). PH-0548 Pareto Navigation Guided Automated Planning for Extreme Hypo-fractionated Prostate Radiotherapy. Radiotherapy and Oncology. 161. S432–S433. 1 indexed citations
6.
Michaelidou, Andriana, Yae‐Eun Suh, Lucy Pike, et al.. (2020). 18F-FDG-PET in guided dose-painting with intensity modulated radiotherapy in oropharyngeal tumours: A phase I study (FiGaRO). Radiotherapy and Oncology. 155. 261–268. 10 indexed citations
7.
Parkinson, Craig, Mererid Evans, Teresa Guerrero Urbano, et al.. (2019). Machine-learned target volume delineation of 18F-FDG PET images after one cycle of induction chemotherapy. Physica Medica. 61. 85–93. 5 indexed citations
8.
Staffurth, John, Nachi Palaniappan, Emiliano Spezi, et al.. (2019). Evaluating the application of Pareto navigation guided automated radiotherapy treatment planning to prostate cancer. Radiotherapy and Oncology. 141. 220–226. 9 indexed citations
9.
Hayhurst, Caroline, Peter Taylor, Andrew Lansdown, et al.. (2019). Current perspectives on recurrent pituitary adenoma: The role and timing of surgery vs adjuvant treatment. Clinical Endocrinology. 92(2). 89–97. 21 indexed citations
10.
Palaniappan, Nachi, et al.. (2018). Trigeminal neuropathy in vestibular schwannoma: a treatment algorithm to avoid long-term morbidity. Acta Neurochirurgica. 160(4). 681–688. 4 indexed citations
11.
Evans, Mererid, Sarah Knott, Chris Hurt, et al.. (2018). PATHOS: A phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for human papillomavirus (HPV)-positive oropharyngeal cancer.. Journal of Clinical Oncology. 36(15_suppl). TPS6097–TPS6097. 12 indexed citations
12.
Palaniappan, Nachi, et al.. (2016). Unilateral radiotherapy for surgically resected lateralized squamous cell carcinoma of the tonsil. Head & Neck. 39(1). 17–23. 30 indexed citations
14.
Tanguay, Jacob, et al.. (2015). What predicts minimal response to abiraterone in metastatic castrate resistant prostate cancer?. Journal of Clinical Oncology. 33(15_suppl). e16103–e16103. 2 indexed citations
15.
Evans, Jessica, M. Button, Satish Kumar, et al.. (2013). Time to prostate specific antigen (PSA) nadir may predict rapid relapse in men with metastatic castration-resistant prostate cancer (CRPC) receiving docetaxel chemotherapy. Medical Oncology. 30(4). 719–719. 15 indexed citations
16.
Al‐Taei, Saly, Ned Powell, Mererid Evans, et al.. (2013). Decreased HPV-specific T cell responses and accumulation of immunosuppressive influences in oropharyngeal cancer patients following radical therapy. Cancer Immunology Immunotherapy. 62(12). 1821–1830. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026